Afghanistan vs Bolivia (Plurinational State of): Proportion of the target population who received a 3rd dose of
Afghanistan
57.0%
in 2024
Bolivia (Plurinational State of)
59.0%
in 2024
Afghanistan rank
146th
Bolivia (Plurinational State of) rank
144th
Proportion of the target population who received a 3rd dose of over time
- Afghanistan
- Bolivia (Plurinational State of)
How they compare
Bolivia (Plurinational State of) currently reports 59.0% against 57.0% in Afghanistan, a difference of 2.0%.
Across all 11 years both countries report, Bolivia (Plurinational State of) has been ahead every year.
Afghanistan ranks 146th and Bolivia (Plurinational State of) ranks 144th of 157 countries.
Bolivia (Plurinational State of) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Bolivia (Plurinational State of) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 60.5% | 78.3% | 17.8% | Bolivia (Plurinational State of) |
| 2020s | 56.4% | 66.8% | 10.4% | Bolivia (Plurinational State of) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Afghanistan or Bolivia (Plurinational State of)?
- Bolivia (Plurinational State of), at 59.0% against 57.0% in Afghanistan as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Afghanistan and Bolivia (Plurinational State of)?
- 2.0%, with Bolivia (Plurinational State of) ahead.
- How many years of comparable data are there for Afghanistan and Bolivia (Plurinational State of)?
- 11 years are reported by both, from 2014 to 2024.
- How do Afghanistan and Bolivia (Plurinational State of) rank globally for proportion of the target population who received a 3rd dose of?
- Afghanistan ranks 146th and Bolivia (Plurinational State of) ranks 144th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.